AstraZeneca (AZN) Stock Chart & Stock Price History £109.02 -48.00 (-0.44%) As of 11:34 AM Eastern Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsDividendHeadlinesInsider TradesSustainabilityBuy This Stock AstraZeneca Stock Price Performance The AstraZeneca (AZN) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 13.67%, with a year-to-date return of 4.15%. In the past month, the stock has increased 7.15%, reflecting recent market activity. As of the latest close, AstraZeneca traded at £109.50 with a market cap of £210.68 billion and volume of 5.88 million shares. Five years ago, the stock traded at GBX 8,419, representing a 29.49% increase over that period. At the time, it had a market cap of £110.48 billion and a volume of 1.16 million shares. Receive AZN Stock News and Ratings via EmailSign-up to receive the latest news and ratings for AstraZeneca and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance-1.82%1 Month Performance+7.15%3 Month Performance+7.58%Year-To-Date Performance+4.15%1 Year Performance-13.67%5 Year Performance+29.49% AZN Stock Chart for Friday, August, 8, 2025 AZN Chart by TradingView AstraZeneca Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization08/07/2025£110.54£109.50-0.94%£110.22£108.105.88 million shs£210.68 billion08/06/2025£112.20£110.54-1.48%£112.74£110.541.45 million shs£212.68 billion08/05/2025£111.06£112.20+1.03%£112.68£111.541.98 million shs£215.88 billion08/04/2025£111.04£111.06+0.01%£111.36£109.342.56 million shs£213.67 billion08/01/2025£113.24£111.04-1.94%£111.62£108.461.86 million shs£213.64 billion07/31/2025£114.98£113.24-1.51%£115.54£112.482.82 million shs£217.88 billion07/30/2025£111.58£114.98+3.05%£114.98£110.624.85 million shs£221.23 billion07/29/2025£107.90£111.58+3.41%£112.28£107.445.59 million shs£214.68 billion07/28/2025£108.64£107.90-0.68%£110.04£106.995.54 million shs£207.60 billion07/25/2025£109.06£108.64-0.39%£109.10£107.666.34 million shs£209.03 billion Get the Latest News and Ratings for AZN and Related StocksEnter your email address below to receive the latest news and analysts' ratings for AstraZeneca and its competitors with MarketBeat's FREE daily newsletter. 07/24/2025£106.57£109.06+2.34%£110£107.361.78 million shs£209.83 billion07/23/2025£103.52£106.57+2.95%£106.84£104.662.05 million shs£205.05 billion07/22/2025£102.42£103.52+1.07%£104.38£101.982.03 million shs£199.18 billion07/21/2025£102.85£102.42-0.42%£102.78£101.782.42 million shs£197.06 billion07/18/2025£103.12£102.85-0.26%£103.52£102.341.60 million shs£197.88 billion07/17/2025£104.36£103.12-1.19%£104.82£1031.46 million shs£198.41 billion07/16/2025£104.96£104.36-0.57%£105.28£103.201.47 million shs£200.79 billion07/15/2025£106.62£104.96-1.56%£107.14£104.821.43 million shs£201.95 billion07/14/2025£106.12£106.62+0.47%£107.62£104.841.20 million shs£205.14 billion07/11/2025£106.26£106.12-0.13%£106.14£104.241.57 million shs£204.18 billion07/10/2025£103.62£106.26+2.55%£106.78£104.601.48 million shs£204.45 billion07/09/2025£101.75£103.62+1.84%£103.76£102.382.46 million shs£199.37 billion07/08/2025£102.18£101.75-0.42%£103.86£101.481.75 million shs£195.77 billion07/07/2025£103.36£102.18-1.14%£103.68£101.72817,727 shs£196.60 billion Related Companies GSK Stock Price Chart Ithaca Energy Stock Price Chart HUTCHMED Stock Price Chart Indivior Stock Price Chart Grainger Stock Price Chart Bloomsbury Publishing Stock Price Chart Origin Enterprises Stock Price Chart India Capital Growth Stock Price Chart Aura Energy Stock Price Chart Pharos Energy Stock Price Chart Receive AZN Stock News and Ratings via EmailSign-up to receive the latest news and ratings for AstraZeneca and its competitors with MarketBeat's FREE daily newsletter. This page (LON:AZN) was last updated on 8/8/2025 by MarketBeat.com Staff From Our PartnersHIDDEN IN THE BOOK OF GENESIS…“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredThe End of Elon Musk…?The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, an...Brownstone Research | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Something big is brewing in Washington. According to my research, an executive order from President Trump c...Weiss Ratings | SponsoredCritical AI announcement set to ignite AI 2.0 A new 100% tariff on imported chips just rattled the tech sector—sending some stocks soaring and others tumbli...Timothy Sykes | SponsoredTrump’s new nightmareAccording to Porter Stansberry and Jeff Brown, a government-led financial mobilization is already reshaping Am...Porter & Company | SponsoredThe Day Silicon DiesThe Day China Left America's Supercomputers in the Dust In 200 seconds, China's quantum computer accomplish...The Oxford Club | SponsoredThis accelerated income plan is solving American's #1 retirement fearThe #1 fear in retirement today? Running out of money. That’s why income expert Tim Plaehn created a simple...Investors Alley | SponsoredSell this, buy thatWhat you don’t own matters just as much as what you do. That’s the thinking behind Eric Fry’s long-time strate...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding AstraZeneca PLC Please log in to your account or sign up in order to add this asset to your watchlist. Share AstraZeneca With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
